Teva’s stock has tumbled over 8 sessions and Morgan Stanley says it could fall 16% more

Teva’s corporate troubles have been exacerbated by wider generic drug industry challenges.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.